Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.
Press releases published on August 20, 2025
Monitaur Launches Guided Risk Assessment and Evidence Mapping to Streamline AI Governance for Enterprise Customers
EIN Presswire
·
August 20, 2025
New capabilities establish consistent methods of evaluating AI risks and further streamline ongoing management of governance requirements. BOSTON, MA, UNITED STATES, August 20, 2025 /EINPresswire.com/ -- Monitaur, the leading AI governance solution for …
Censinet Appoints James C. Foster as Board Chairman
EIN Presswire
·
August 20, 2025
Veteran Director Brings Proven Success Scaling Private, Public Companies to Accelerate Censinet’s Mission at the Intersection of Healthcare, Cyber GRC, and AI BOSTON, MA, UNITED STATES, August 20, 2025 /EINPresswire.com/ -- Censinet, the leading …
How Mass Spectrometry Solves Critical Hurdles in Phosphorylated Protein Analysis
EIN Presswire
·
August 20, 2025
Phosphorylated Protein Analysis represents a critical approach for elucidating cellular signaling, cell cycle regulation, and metabolic pathway control. BOSTON, MA, UNITED STATES, August 20, 2025 /EINPresswire.com/ -- Phosphorylated Protein Analysis …
TTA Recognized with Multiple 2025 Brandon Hall Group™ HCM Excellence Awards® in Leadership Development
EIN Presswire
·
August 20, 2025
TTA, the leading provider of L…
Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates
GlobeNewswire
·
August 20, 2025
Product sales from Olverembatinib in the first half of 2025 increased 93% year-over-year to US$30.3 million (RMB217.4 million), primarily attributable to the expansion of NRDL coverage Commenced commercial sales of Lisaftoclax in China, following approval …
Global Enzymes Market Set to Reach $20.4 Billion by 2029 | Asia-Pacific Emerges as a Hotspot
GlobeNewswire
·
August 20, 2025
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets, the global enzymes market is experiencing robust growth, driven by innovations in biotechnology, increasing demand in biopharmaceutical production, and rising environmental …
RxTran Ensures Compliance With Prescription Label Translation Requirements Under Washington State’s ESHB 1852
EIN Presswire
·
August 20, 2025
Bill mandates pharmacies to provide prescription drug labels translated into the state’s largest non-English languages and imposes fines for failing to comply BOSTON, MA, UNITED STATES, August 20, 2025 /EINPresswire.com/ -- RxTran, a division of …
NowVertical Group Announces Second Quarter 2025 Earnings Release Date and Financial Update Webinar
GlobeNewswire
·
August 20, 2025
TORONTO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) (“NowVertical” or the “Company”), a leading data and AI solutions provider, will announce its 2025 second quarter results after the market close on Wednesday, August 27, 2025. …
Inventronics Announces 2025 Q2 Financial Results
GlobeNewswire
·
August 20, 2025
CALGARY, Alberta, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Inventronics Limited (the “Corporation”) (IVX:TSX Venture), a designer and manufacturer of enclosures for the telecommunications, cable, electric distribution, energy, and other industries in Canada and …
Larkspur Biosciences Announces Discovery of LRK-4189, a First-in-Class Degrader of the Lipid Kinase PIP4K2C, for the Treatment of Microsatellite Stable (MSS) Colorectal Cancer at the ACS Fall 2025 Meeting
GlobeNewswire
·
August 20, 2025
CAMBRIDGE, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Larkspur Biosciences, a company pioneering a new wave in cancer therapy that destroys tumors by targeting cancer cell fitness, today announced the discovery of LRK-4189, a first-in-class degrader of the …
BioAge Labs to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 20, 2025
EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human …
iRhythm Technologies to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 20, 2025
SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is …
Onco360® Has Been Selected as a Specialty Pharmacy Partner for HERNEXEOS® (zongertinib)
GlobeNewswire
·
August 20, 2025
LOUISVILLE, K.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Boehringer Ingelheim for Hernexeos® (Zongertinib). The Food and Drug Administration approved …
BlackLine Announces Participation in Upcoming Investor Conference
GlobeNewswire
·
August 20, 2025
LOS ANGELES, Aug. 20, 2025 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL) today announced that BlackLine’s management team will participate in the following upcoming investor conference: Citi’s 2025 Global TMT Conference Wednesday, September 3, 2025 …
3D Systems Announces Chief Financial Officer Transition
GlobeNewswire
·
August 20, 2025
3D Systems’ Executive Vice President, Phyllis Nordstrom to Serve as Interim Chief Financial Officer ROCK HILL, S.C., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE: DDD) announced that Jeffrey D. Creech is stepping down as the company’s Chief …
Astera Labs Announces Third Quarter 2025 Financial Conference Participation
GlobeNewswire
·
August 20, 2025
SAN JOSE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced its participation in financial conferences for the third quarter …
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
August 20, 2025
SEATTLE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has closed the sale of 3,358,208 shares of its common …
TruGolf Reports Second Quarter 2025 Financial Results Q2 2025 Sales Grow 11.3% Over Q2 2024
GlobeNewswire
·
August 20, 2025
Salt Lake City, Utah, Aug. 20, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading provider of golf simulator software and hardware, announced today its second quarter 2025 results. The Company reported sales of $4.3 million, up 11.3% …
NurExone Biologic Announces Preclinical Evidence of Structural Repair in Injured Spinal Cord Tissue following ExoPTEN Treatment
GlobeNewswire
·
August 20, 2025
TORONTO and HAIFA, Israel, Aug. 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce new preclinical imaging results providing anatomical evidence consistent with …
Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity
GlobeNewswire
·
August 20, 2025
– U.S. Food and Drug Administration accepts sNDA for filing with priority review; sets PDUFA goal date of December 20, 2025 -- – European Medicines Agency accepts and validates submission for Type II variation MAA for setmelanotide to treat acquired …